Quick Answer
Anterix Inc. reported Total Revenue of $6.03 million for fiscal year 2025.
Anterix Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $6.03M +43.9% |
$4.19M +118.4% |
$1.92M +77.0% |
$1.08M +17.7% |
$921.0K -41.1% |
$1.56M -75.9% |
| Net Income | -$11.37M -24.6% |
-$9.13M +44.1% |
-$16.32M +56.5% |
-$37.52M +31.1% |
-$54.43M -44.6% |
-$37.64M +10.4% |
| Diluted EPS | -$0.61 -24.5% |
-$0.49 +43.7% |
-$0.87 +58.0% |
-$2.07 +33.9% |
-$3.13 -36.7% |
-$2.29 |
| Total Assets | $333.10M +2.5% |
$324.89M +16.6% |
$278.56M +0.2% |
$278.04M +9.9% |
$253.06M -5.4% |
$267.40M +35.9% |
| Cash and Equivalents | $47.37M -21.8% |
$60.58M +40.3% |
$43.18M -59.1% |
$105.62M -10.1% |
$117.54M -14.5% |
$137.45M +79.2% |
| Stockholders Equity | $156.60M -2.8% |
$161.03M -10.4% |
$179.79M -3.5% |
$186.30M -12.3% |
$212.51M -13.3% |
$245.07M +35.6% |
| R&D Expense | $5.74M +0.7% |
$5.70M +28.3% |
$4.44M +23.5% |
$3.59M -17.3% |
$4.34M +47.1% |
$2.95M +29.2% |
| Operating Income | -$11.71M -15.7% |
-$10.12M +38.5% |
-$16.46M +55.3% |
-$36.85M +32.8% |
-$54.81M -46.0% |
-$37.53M +12.2% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 18.61M +0.9% |
18.45M -2.5% |
18.92M +3.0% |
18.38M +4.0% |
17.67M +2.8% |
17.18M +16.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $1.57M | +0.4% | +1.4% |
| Net Income | December 31, 2025 | -$6.60M | -185.6% | -112.3% |
| Diluted EPS | December 31, 2025 | -$0.35 | -185.4% | -112.2% |
| Total Assets | December 31, 2025 | $417.00M | +27.6% | -0.8% |
| Cash and Equivalents | December 31, 2025 | $29.53M | +2.6% | -24.4% |
| Stockholders Equity | December 31, 2025 | $235.95M | +63.0% | -1.8% |
| R&D Expense | December 31, 2025 | $1.10M | -1.4% | -8.9% |
| Operating Income | December 31, 2025 | -$9.06M | -228.9% | -114.9% |
| Gross Profit | June 30, 2019 | -$1.04M | -278.1% | -816.8% |
| Shares Outstanding | December 31, 2025 | 18.73M | +0.8% | +0.1% |
- Anterix Inc. reported Total Revenue of $6.03 million for fiscal year 2025.
- Anterix Inc. showed an increase of +43.9% in Total Revenue compared to the prior fiscal year.
- Anterix Inc. reported Net Income of -$11.37 million for fiscal year 2025.
- Anterix Inc. showed a decrease of -24.6% in Net Income compared to the prior fiscal year.
- Anterix Inc. reported Diluted EPS of $0.61 per share (loss) for fiscal year 2025.
- Anterix Inc. showed a decrease of -24.5% in Diluted EPS compared to the prior fiscal year.
- Anterix Inc. reported Total Assets of $333.10 million for fiscal year 2025.
- Anterix Inc. showed an increase of +2.5% in Total Assets compared to the prior fiscal year.
- Anterix Inc. reported Cash and Equivalents of $47.37 million for fiscal year 2025.
- Anterix Inc. showed a decrease of -21.8% in Cash and Equivalents compared to the prior fiscal year.
- Anterix Inc. reported Stockholders Equity of $156.60 million for fiscal year 2025.
- Anterix Inc. showed a decrease of -2.8% in Stockholders Equity compared to the prior fiscal year.
- Anterix Inc. reported R&D Expense of $5.74 million for fiscal year 2025.
- Anterix Inc. showed an increase of +0.7% in R&D Expense compared to the prior fiscal year.
- Anterix Inc. reported Operating Income of -$11.71 million for fiscal year 2025.
- Anterix Inc. showed a decrease of -15.7% in Operating Income compared to the prior fiscal year.
- Anterix Inc. reported Gross Profit of -$752.0 thousand for fiscal year 2019.
- Anterix Inc. showed an increase of +51.3% in Gross Profit compared to the prior fiscal year.
- Anterix Inc. reported Shares Outstanding of 18.61 million shares for fiscal year 2025.
- Anterix Inc. showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: